Investigation on effects of sleep apnea syndrome (SAS) and its CPAP treatment on serum KL-6 level.

Investigation on effects of sleep apnea syndrome (SAS) and its CPAP treatment on serum KL-6 level. - Investigation on effects of sleep apnea syndrome (SAS) and its CPAP treatment on serum KL-6 level.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000032953

Enrollment

100

Registered

2018-07-01

Start date

2017-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sleep apnea syndrome

Interventions

Positive Airway Pressure treatment (CPAP) for 6 months

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)Patients with sleep apnea syndrome who first visit a sleep clinic at our university hospital. 2)Patients with informed concent.

Exclusion criteria

Exclusion criteria: 1)Patients with interstitial lung disease 2)Patients with hypoxemia (at awake resting SpO 2 <95%) 3)Patients with infectious pneumonia or drug pneumonia or advanced stage cancer or pulmonary tuberculosis or alveolar proteinosis. 4)Patients in a state of shock 5)Patients with disturbance of consciouness 6)Patients on a ventilator 7)patients who are cnsiderded unsuitable for the trial by attending physician

Design outcomes

Primary

Measure	Time frame
The relationship between sleep apnea syndrome(SAS) and serum KL-6 level, and the effect of CPAP treatment on its level 6 months after the start of treatment.	—

Countries

Japan

Contacts

Public ContactKenjirou Wasano

Kurume University school of medicine Depertment of Neuropsychiatry

wasano_kenjirou@med.kurume-u.ac.jp+81-942-31-7564

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026